Lab
Be Well Primary Health Care Center, LLC
Be Well Primary Health Care Center, LLC was paid $18.06M by Medicaid between Jan 2018 and Dec 2024, across 179 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoBE WELL PRIMARY HEALTH CARE CENTER, LLC
BROOKLYN, NY 11210
BROOKLYN, NY 11210
33aNPI1083623409assigned 08/05/2006
33bProvider typeClinical Medical Laboratory
28Total paid$18.06M
24GClaims566,531
24DCodes billed179
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#18 of 116
Median peer was paid$618K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,051 | $1.14M | |
| 2019 | 59,236 | $1.52M | |
| 2020 | 82,885 | $2.50M | |
| 2021 | 113,168 | $3.56M | |
| 2022 | 105,429 | $3.79M | |
| 2023 | 89,080 | $3.09M | |
| 2024incomplete | 78,682 | $2.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 80,669 | 34,202 | $3.12M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15% | 38,017 | 26,730 | $2.68M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.0% | 13,982 | 11,134 | $1.26M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.9% | 53,664 | 8,109 | $1.25M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 5.1% | 14,432 | 9,796 | $924K |
| D9999 | Unspecified adjunctive procedure, by report | 4.0% | 6,948 | 5,183 | $720K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.5% | 9,331 | 5,769 | $640K |
| 99401 | 3.3% | 17,592 | 16,490 | $595K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.0% | 1,136 | 1,050 | $546K |
| 99000 | 2.6% | 21,521 | 19,953 | $469K | |
| 93976 | 2.3% | 1,383 | 1,349 | $416K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.9% | 3,252 | 3,023 | $349K |
167 more codes
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.8% | 3,388 | $324K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 1,042 | $273K |
| 97032 | 1.2% | 18,259 | $224K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.2% | 8,486 | $224K |
| 92552 | 1.2% | 4,104 | $221K | |
| 97035 | 1.2% | 19,253 | $216K | |
| 97124 | 1.2% | 12,083 | $213K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 1.1% | 5,386 | $198K |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.0% | 5,744 | $189K |
| 93880 | <1% | 440 | $173K | |
| D0999 | Unspecified diagnostic procedure, by report | <1% | 1,674 | $169K |
| 99051 | <1% | 7,457 | $153K | |
| 97162 | <1% | 2,729 | $144K | |
| 92133 | <1% | 2,211 | $139K | |
| 92250 | <1% | 2,181 | $136K | |
| 92083 | <1% | 1,865 | $126K | |
| D0120 | Dental checkup, returning patient | <1% | 5,350 | $105K |
| 92015 | Determination of refractive state | <1% | 4,726 | $104K |
| 92134 | <1% | 1,307 | $95K | |
| 92201 | <1% | 1,825 | $91K | |
| 97116 | <1% | 5,000 | $90K | |
| 99406 | <1% | 2,006 | $80K | |
| 29540 | <1% | 535 | $77K | |
| 97802 | <1% | 3,444 | $73K | |
| 36416 | <1% | 2,428 | $64K | |
| 92202 | <1% | 1,207 | $64K | |
| 97803 | <1% | 3,257 | $63K | |
| 99173 | <1% | 2,691 | $58K | |
| 92020 | <1% | 1,088 | $54K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,880 | $52K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,601 | $47K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,151 | $46K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,286 | $46K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,776 | $46K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 2,480 | $45K |
| 76830 | Ultrasound, transvaginal | <1% | 790 | $40K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 2,316 | $39K |
| 99243 | <1% | 310 | $39K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,510 | $32K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 517 | $28K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 740 | $27K |
| 11721 | <1% | 545 | $26K | |
| 99441 | <1% | 267 | $26K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 436 | $25K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,095 | $24K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,556 | $22K |
| 92082 | <1% | 432 | $22K | |
| 99385 | <1% | 468 | $20K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 2,008 | $18K |
| 93970 | <1% | 64 | $16K | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 419 | $16K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 1,477 | $15K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 500 | $15K |
| 90686 | <1% | 940 | $14K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 145 | $14K |
| 92226 | <1% | 313 | $14K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 689 | $12K |
| 99386 | <1% | 312 | $11K | |
| 20552 | <1% | 41 | $11K | |
| 20550 | <1% | 38 | $9K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 432 | $8K |
| 99442 | <1% | 73 | $8K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 518 | $6K |
| D0140 | Limited oral evaluation - problem focused | <1% | 481 | $6K |
| D4341 | <1% | 812 | $6K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 31 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $5K |
| 95812 | <1% | 47 | $5K | |
| 99408 | <1% | 225 | $5K | |
| 97163 | <1% | 56 | $5K | |
| 92225 | <1% | 72 | $4K | |
| 97164 | <1% | 176 | $4K | |
| 3074F | <1% | 3,838 | $4K | |
| 17110 | <1% | 15 | $3K | |
| D2330 | <1% | 201 | $3K | |
| 76514 | <1% | 31 | $3K | |
| 3077F | <1% | 2,229 | $3K | |
| 3078F | <1% | 3,144 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 512 | $3K |
| 90461 | <1% | 977 | $3K | |
| 3079F | <1% | 2,819 | $3K | |
| 93923 | <1% | 42 | $2K | |
| 93000 | <1% | 825 | $2K | |
| D1110 | Prophylaxis - adult | <1% | 2,078 | $2K |
| A4402 | Lubricant, per ounce | <1% | 3,295 | $2K |
| 82607 | <1% | 195 | $2K | |
| 82728 | <1% | 191 | $2K | |
| 73630 | <1% | 280 | $2K | |
| 80061 | Lipid panel | <1% | 228 | $2K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,582 | $1K |
| 97018 | <1% | 129 | $1K | |
| 81025 | <1% | 440 | $1K | |
| 95886 | <1% | 13 | $1K | |
| 3080F | <1% | 703 | $1K | |
| 80050 | General health panel | <1% | 54 | $1K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 2,073 | $1K |
| 84439 | <1% | 150 | $994.87 | |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 624 | $991.97 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 152 | $990.52 |
| 85018 | <1% | 1,578 | $963.09 | |
| 83540 | <1% | 203 | $856.02 | |
| 82977 | <1% | 169 | $734.40 | |
| 0011A | <1% | 25 | $680.36 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 99 | $661.86 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 54 | $661.61 |
| D0210 | Intraoral - complete series of radiographic images | <1% | 528 | $652.80 |
| 83615 | <1% | 154 | $635.64 | |
| 84550 | <1% | 184 | $595.87 | |
| 90674 | <1% | 37 | $585.43 | |
| 84100 | <1% | 171 | $583.73 | |
| 96127 | <1% | 110 | $563.31 | |
| 83735 | <1% | 106 | $486.96 | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 4,272 | $413.22 |
| 82550 | <1% | 87 | $392.88 | |
| 3075F | <1% | 453 | $386.50 | |
| 36410 | <1% | 14 | $383.65 | |
| 90670 | <1% | 49 | $377.50 | |
| 90734 | <1% | 28 | $337.37 | |
| 99072 | <1% | 710 | $313.00 | |
| 80053 | Comprehensive metabolic panel | <1% | 50 | $297.37 |
| 90656 | <1% | 29 | $292.18 | |
| 90715 | <1% | 12 | $267.29 | |
| 99070 | <1% | 19,605 | $264.28 | |
| A4559 | Coupling gel or paste, for use with ultrasound device, per oz | <1% | 14,713 | $235.38 |
| 99459 | <1% | 41 | $217.20 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $214.20 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 60 | $185.96 |
| 1160F | <1% | 2,050 | $185.00 | |
| 1159F | <1% | 1,928 | $185.00 | |
| 90633 | <1% | 42 | $182.90 | |
| A4268 | Contraceptive supply, condom, female, each | <1% | 436 | $175.15 |
| D0274 | Bitewings - four radiographic images | <1% | 870 | $132.60 |
| 86580 | <1% | 13 | $125.74 | |
| D1330 | <1% | 972 | $107.91 | |
| 99381 | <1% | 38 | $107.10 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $95.16 |
| D1120 | Dental cleaning, child | <1% | 502 | $68.00 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 143 | $52.00 |
| 82948 | <1% | 15 | $51.40 | |
| 90716 | <1% | 13 | $33.33 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 482 | $27.89 |
| 83986 | <1% | 15 | $27.86 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 9,998 | $22.50 |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 467 | $22.10 |
| A6413 | Adhesive bandage, first-aid type, any size, each | <1% | 14,296 | $18.40 |
| 90707 | <1% | 12 | $16.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 125 | $16.91 |
| A4265 | Paraffin, per pound | <1% | 67 | $15.81 |
| A6455 | Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard | <1% | 378 | $7.19 |
| 81003 | <1% | 236 | $6.53 | |
| 3008F | <1% | 11,013 | $0.26 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 4,190 | $0.00 |
| 1000F | 0% | 744 | $0.00 | |
| 0513F | 0% | 1,307 | $0.00 | |
| 1220F | 0% | 2,027 | $0.00 | |
| 4293F | 0% | 128 | $0.00 | |
| 3011F | 0% | 13 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 0% | 69 | $0.00 |
| 90474 | 0% | 12 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 18 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 27 | $0.00 |
| 3044F | 0% | 13 | $0.00 | |
| 3016F | 0% | 2,019 | $0.00 | |
| 99080 | 0% | 245 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 25 | $0.00 |
| 2022F | 0% | 41 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTEPANKOVSKIY, YEVGENIY (CHIEF EXECUTIVE OFFICER)